$210.64+10.07% · 3M
Moving avg
1W+1.30%
1M+6.79%
3M+9.17%
6M+7.19%
YTD+18.46%
1Y+56.10%
3Y-22.77%
5Y-38.68%
52-week range
$124.5690% of range$219.72
Company health
Value4/6
Growth1/6
Profitability5/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (755%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$31.12B
Enterprise value
$33.21B
P/E ratio (TTM)
21.71x
P/S ratio (TTM)
3.05x
EV/EBITDA
12.29x
Per share & returns
EPS (TTM)
$9.32
Dividend yield
0.00%
Beta (1Y)
0.16
30-day change
+6.79%
Trading
Volume (24h)
350.65K
Previous close
$208.87
Shares outstanding
147.75M
About Biogen Inc.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
Symbol
BIIB
Biogen Inc. is a large-cap healthcare company in the Drug Manufacturers - General industry. Its shares are listed on NASDAQ (United States) and trade under the ticker BIIB.
Frequently asked questions
What is Biogen Inc.'s market cap?
Biogen Inc. (BIIB) has a market capitalization of $31.12B.
What is Biogen Inc.'s P/E ratio?
Biogen Inc. trades at a price-to-earnings (P/E) ratio of 21.71.
What exchange does BIIB trade on?
BIIB trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,217.09-0.26%
$1.15T cap
Johnson & JohnsonJNJ
$261.54+0.26%
$630.28B cap
AbbVie Inc.ABBV
$250.93+0.87%
$443.34B cap
UnitedHealth Group IncorporatedUNH
$402.43-0.78%
$365.46B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.59+1.26%
$332.41B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap